Effect analysis of PLLA filler injection

Volumizing effect of poly-L-lactic acid (PLLA) filler (Sculptra®) injection in Korean

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0001442

Enrollment

Registered

2015-04-08

Start date

2012-10-17

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : One side of cheek: Poly L lactic acid, 4cc, 3 times monthly, total 12cc, Subcutaneous injection Other side of cheek: Poly L lactic acid, 6cc, 2 times monthly, total 12cc, Subcutane

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy volunteers over aged 30 years with facial volume loss scale 2 or 3 grade

Exclusion criteria

Exclusion criteria: 1) Patients with severe chronic wasting disease 2) Patients with impaired blood clotting 3) Pregnancy, breastfeeding women who are pregnant or plan for a trial period 4) Patients with infectious skin disease on the face 5) When receiving the treatments that can affect the shape and volume of the latest face within 6 months 6) During the trial period, other cosmetic procedure if you have planned 7) Persons who are participating in other clinical studies 8) Communication is impossible or difficult to follow the instructions 9) Not suitable for this trial under tester decision

Design outcomes

Primary

Measure	Time frame
Facial volume loss scale, Objective volume change with Vectra	—

Secondary

Measure	Time frame
Facial volume change with different injection schedules	—

Countries

Korea, Republic of

Contacts

Public ContactChang Hun Huh

Seoul National University Bundang Hospital

Outcome results